Free Trial
→ I’m sounding the alarm (From Porter & Company) (Ad)tc pixel Free GRCL Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Gracell Biotechnologies (GRCL) Short Interest Ratio & Short Volume

Gracell Biotechnologies logo
Compare

Gracell Biotechnologies Short Interest Overview

As of January 31, 2024, Gracell Biotechnologies (GRCL) had a short interest of 1.19 million shares sold short, representing 1.64% of the public float. This marks a 171.57% increase in short interest since the prior report. The short interest ratio (days to cover) is 0.9, meaning it would take 0.9 days of the average trading volume of 1.32 million shares to cover all short positions.

Current Short Interest
1,190,000 shares
Previous Short Interest
438,200 shares
Change Vs. Previous Month
171.57%
Dollar Volume Sold Short
$12.16 million
Short Interest Ratio
0.9 Days to Cover
Last Record Date
January 31, 2024
Outstanding Shares
72,678,000 shares
Float Size
72,660,000 shares
Short Percent of Float
1.64%
Today's Trading Volume
0 shares
Average Trading Volume
1,315,803 shares
Today's Volume Vs. Average
0%
Short Selling Gracell Biotechnologies?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Gracell Biotechnologies and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GRCL Short Interest Over Time

GRCL Days to Cover Over Time

GRCL Percentage of Float Shorted Over Time

Gracell Biotechnologies Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20241,190,000 shares $12.16 million +171.6%1.6%0.9 $10.22
1/15/2024438,200 shares $4.38 million -21.0%0.6%0.4 $10.00
12/31/2023554,400 shares $5.57 million -42.6%0.8%0.6 $10.04
12/15/2023965,800 shares $5.47 million -4.4%1.4%1.1 $5.66
11/30/20231,010,000 shares $4.92 million +9.5%1.4%2 $4.87
11/15/2023922,400 shares $4.21 million +2.6%1.3%2.1 $4.56
10/31/2023898,700 shares $3.02 million +7.9%1.1%2.2 $3.36
10/15/2023833,100 shares $2.02 million +1.0%1.0%2.3 $2.43
9/30/2023824,900 shares $2.38 million -10.6%1.0%2.6 $2.88
9/15/2023922,900 shares $2.98 million +3.8%1.1%4.2 $3.23
8/31/2023888,800 shares $2.92 million +11.2%1.2%2.7 $3.28
8/15/2023799,100 shares $3.17 million +6.8%1.0%2.4 $3.97
7/31/2023748,300 shares $2.82 million -24.8%1.3%2.2 $3.77
7/15/2023995,400 shares $4.88 million +4.9%1.8%3 $4.90
6/30/2023949,300 shares $3.62 million +192.5%1.7%3 $3.81
6/15/2023324,500 shares $1.90 million +20.9%0.6%1.2 $5.84
5/31/2023268,400 shares $735.42 thousand -14.7%0.5%1.9 $2.74
5/15/2023314,600 shares $701.56 thousand -15.5%0.6%3.1 $2.23
4/30/2023372,100 shares $647.45 thousand -4.9%0.6%1.9 $1.74
4/15/2023391,200 shares $739.37 thousand -9.2%0.7%1.2 $1.89
3/31/2023430,800 shares $801.29 thousand +14.8%0.7%1.2 $1.86
3/15/2023375,400 shares $683.23 thousand +10.0%0.6%1 $1.82
2/28/2023341,300 shares $686.01 thousand +35.0%0.6%0.9 $2.01
2/15/2023252,800 shares $535.94 thousand -14.8%0.4%0.6 $2.12
1/31/2023296,700 shares $637.91 thousand +131.8%0.5%0.8 $2.15
1/15/2023128,000 shares $285.44 thousand -23.2%0.2%1 $2.23
12/30/2022166,600 shares $383.18 thousand -27.6%0.3%1.7 $2.30
12/15/2022230,200 shares $580.10 thousand +49.0%0.4%2.5 $2.52
11/30/2022154,500 shares $502.13 thousand -18.4%0.3%3.5 $3.25
11/15/2022189,300 shares $702.30 thousand -41.7%0.3%4 $3.71
10/31/2022324,800 shares $1.04 million +31.1%0.6%5.9 $3.19
10/15/2022247,700 shares $745.58 thousand -5.7%0.4%4.1 $3.01
9/30/2022262,600 shares $845.57 thousand +29.8%0.5%4 $3.22
9/15/2022202,300 shares $445.06 thousand -27.8%0.4%2.3 $2.20
8/31/2022280,200 shares $703.30 thousand -7.3%0.5%3 $2.51
8/15/2022302,400 shares $1.02 million -53.0%0.5%2.7 $3.38
7/31/2022643,400 shares $2.27 million +2.6%1.1%5.3 $3.53
7/15/2022627,300 shares $2.57 million -46.8%1.1%5.2 $4.10
6/30/20221,180,000 shares $6.49 million +2.6%2.1%8.4 $5.50
6/15/20221,150,000 shares $4.27 million +43.4%2.0%6.4 $3.71
5/31/2022802,000 shares $2.64 million +38.6%1.4%3.8 $3.29
5/15/2022578,600 shares $1.93 million -5.1%1.0%2.8 $3.33
4/30/2022609,600 shares $1.37 million -3.8%1.1%2.5 $2.25
4/15/2022633,700 shares $1.31 million -41.3%1.2%2.1 $2.06
3/31/20221,080,000 shares $2.52 million -10.7%N/A0 $2.33
3/15/20221,210,000 shares $2.36 million +2.5%2.2%4.6 $1.95
2/28/20221,180,000 shares $3.76 million +12.4%2.1%4.4 $3.19
2/15/20221,050,000 shares $4.11 million +1.0%1.8%1.8 $3.91
1/31/20221,040,000 shares $3.69 million -14.8%2.9%1.6 $3.55
1/15/20221,220,000 shares $5.60 million -8.3%N/A2.1 $4.59
12/31/20211,330,000 shares $8.03 million +3.9%2.3%2.4 $6.04
12/15/20211,280,000 shares $7.99 million +11.3%2.2%2.4 $6.24
11/30/20211,150,000 shares $8.90 million +71.0%2.0%2.3 $7.74
11/15/2021672,600 shares $7.34 million +6.1%1.2%1.5 $10.92
10/29/2021634,200 shares $6.79 million -23.0%1.1%7.8 $10.70
10/15/2021823,400 shares $10.90 million -25.2%1.4%10.1 $13.24
9/30/20211,100,000 shares $15.26 million -3.5%1.9%14.5 $13.87
9/15/20211,140,000 shares $16.92 million -5.0%2.0%12.6 $14.84
8/31/20211,200,000 shares $12.52 million -10.5%2.1%11.8 $10.43
8/13/20211,340,000 shares $15.53 million No Change2.3%10.7 $11.59

GRCL Short Interest - Frequently Asked Questions

What is Gracell Biotechnologies' current short interest?

Short interest is the volume of Gracell Biotechnologies shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 1,190,000 shares of GRCL short. 1.64% of Gracell Biotechnologies' shares are currently sold short. Learn More on Gracell Biotechnologies' current short interest.

What is a good short interest ratio for Gracell Biotechnologies?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GRCL shares currently have a short interest ratio of 0.9. Learn More on Gracell Biotechnologies's short interest ratio.

What is a good short interest percentage for Gracell Biotechnologies?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.64% of Gracell Biotechnologies' floating shares are currently sold short.

Is Gracell Biotechnologies' short interest increasing or decreasing?

Gracell Biotechnologies saw a increase in short interest in January. As of January 31st, there was short interest totaling 1,190,000 shares, an increase of 171.6% from the previous total of 438,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Gracell Biotechnologies' float size?

Gracell Biotechnologies currently has issued a total of 72,678,000 shares. Some of Gracell Biotechnologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Gracell Biotechnologies currently has a public float of 72,660,000 shares.

How does Gracell Biotechnologies' short interest compare to its competitors?

1.64% of Gracell Biotechnologies' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Gracell Biotechnologies: Definium Therapeutics, Inc. (10.08%), Hyperion DeFi, Inc. (11.06%), Adial Pharmaceuticals, Inc. (3.50%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors Company ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Corporation ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply Company ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Gracell Biotechnologies stock?

Short selling GRCL is an investing strategy that aims to generate trading profit from Gracell Biotechnologies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Gracell Biotechnologies?

A short squeeze for Gracell Biotechnologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GRCL, which in turn drives the price of the stock up even further.

How often is Gracell Biotechnologies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRCL, twice per month. The most recent reporting period available is January, 31 2024.

What do GRCL's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like GRCL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Related Companies
Short Interest Tools

This page (NASDAQ:GRCL) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners
Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
I’m sounding the alarm
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
One executive order. The biggest wealth transfer of your lifetime.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
The AI stocks about to become worthless (and one that isn't)
Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...
InvestorPlace | Sponsoredtc pixel